Chargement en cours...
Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer
BACKGROUND: As one of the many breast cancer subtypes, human epidermal growth factor receptor 2 (Her2)-positive breast cancer has higher invasiveness and poor prognosis, although the advent of anti-Her2 drugs has brought good news to patients. However, the emergence of drug resistance still limits i...
Enregistré dans:
| Publié dans: | Cancer Cell Int |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7161270/ https://ncbi.nlm.nih.gov/pubmed/32322168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-020-01175-1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|